Bruton’s tirosine kinase inhibitors in high-risk patients with chronic lymphocytic leukemia: modeled impact on the mortality from malignant neoplasms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bruton’s tirosine kinase inhibitors in high-risk patients with chronic lymphocytic leukemia: modeled impact on the mortality from malignant neoplasms

Published:2023 Issue:3 Volume: Page:59
ISSN:2219-0678
Container-title:Medical Technologies. Assessment and Choice
language:en
Short-container-title:Med. Tech. Asses. and Choice

Author:

Avxentyev N.A.^ORCID,Makarov A.S.^ORCID,Sisigina N.N.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Public Health, Environmental and Occupational Health,Health Policy,Biomedical Engineering,Medicine (miscellaneous)

Reference17 articles.

1. Kaprin AD, Starinskij VV, Petrova GV. Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu. M.: MNIOI im. P.A. Gercena. Filial FGBU «NMIRC» Minzdrava Rossii; 2022. (In Russ.)

2. Rosstat — EMISS. Accessed July 14, 2023. (In Russ.). https://www.fedstat.ru/

3. Klinicheskie rekomendacii. Khronicheskiy limfotsitarnyj lejkoz/limfoma iz malykh limfotsitov. Accessed February 15, 2022. (In Russ.). https://cr.minzdrav.gov.ru/recomend/134

4. Klinicheskie rekomendacii. Khronicheskiy limfotsitarnyj lejkoz/limfoma iz malykh limfotsitov. Proekt 2021—2022. Accessed February 15, 2022. (In Russ.). https://rusoncohem.ru/klinrec/3348-2

5. Ocenka osvedomlennosti vrachej v oblasti onkogematologii, IV kvartal 2021 goda. MAR Consult., 2022. Accessed July 14, 2023. (In Russ.). https://marconsult.ru/opros-onkogematologov/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP